Voss Veksel- og Landmandsbank ASA (OSL:VVL)
384.00
-4.00 (-1.03%)
Aug 1, 2025, 3:18 PM CET
CTI BioPharma Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Interest Income on Loans | 349.45 | 348.31 | 295.43 | 174.78 | 126.4 | 146.78 | Upgrade |
Interest Income on Investments | 2.87 | 4.77 | 3.36 | 4.57 | 2.08 | 7.44 | Upgrade |
Total Interest Income | 352.32 | 353.08 | 298.79 | 179.35 | 128.48 | 154.21 | Upgrade |
Interest Paid on Deposits | 210.87 | 209.61 | 162.4 | 65.45 | 34.66 | 59.51 | Upgrade |
Net Interest Income | 141.45 | 143.48 | 136.39 | 113.91 | 93.83 | 94.71 | Upgrade |
Net Interest Income Growth (YoY) | 3.71% | 5.20% | 19.74% | 21.40% | -0.93% | -3.23% | Upgrade |
Gain (Loss) on Sale of Investments | 25.53 | 23.76 | 19.64 | 2.69 | 2.27 | -0.45 | Upgrade |
Other Non-Interest Income | 26.31 | 24.5 | 19.65 | 15.37 | 13.61 | 12.39 | Upgrade |
Total Non-Interest Income | 51.84 | 48.26 | 39.28 | 18.06 | 15.88 | 11.94 | Upgrade |
Non-Interest Income Growth (YoY) | 31.97% | 22.85% | 117.54% | 13.74% | 32.93% | -11.38% | Upgrade |
Revenues Before Loan Losses | 193.29 | 191.74 | 175.67 | 131.97 | 109.7 | 106.65 | Upgrade |
Provision for Loan Losses | 1.84 | 2.02 | 4.42 | 1.73 | 0.22 | 7.53 | Upgrade |
191.45 | 189.72 | 171.25 | 130.23 | 109.48 | 99.12 | Upgrade | |
Revenue Growth (YoY) | 11.79% | 10.78% | 31.50% | 18.96% | 10.45% | -8.97% | Upgrade |
Salaries and Employee Benefits | 37.03 | 35.58 | 31.18 | 24.25 | 22.76 | 21.47 | Upgrade |
Occupancy Expenses | 1.4 | 1.27 | 1.42 | 1.53 | 1.79 | 1.99 | Upgrade |
Selling, General & Administrative | 3.84 | 3.84 | 4 | 3.43 | 2.49 | 2.17 | Upgrade |
Other Non-Interest Expense | 32.21 | 30.99 | 33.58 | 30.52 | 24.44 | 30.44 | Upgrade |
Total Non-Interest Expense | 74.48 | 71.68 | 70.17 | 59.73 | 51.48 | 56.07 | Upgrade |
EBT Excluding Unusual Items | 116.97 | 118.04 | 101.08 | 70.51 | 58 | 43.05 | Upgrade |
Pretax Income | 116.97 | 118.04 | 101.08 | 70.51 | 58 | 43.05 | Upgrade |
Income Tax Expense | 26.97 | 27.25 | 23.43 | 16.31 | 13.4 | 9.79 | Upgrade |
Net Income | 89.82 | 90.79 | 77.65 | 54.2 | 44.6 | 33.26 | Upgrade |
Net Income to Common | 89.82 | 90.79 | 77.65 | 54.2 | 44.6 | 33.26 | Upgrade |
Net Income Growth | 15.67% | 16.91% | 43.28% | 21.51% | 34.11% | -28.87% | Upgrade |
Basic Shares Outstanding | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade |
Diluted Shares Outstanding | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade |
Shares Change (YoY) | -0.66% | -0.73% | 2.35% | 0.56% | 2.87% | 10.88% | Upgrade |
EPS (Basic) | 38.47 | 38.91 | 33.04 | 23.60 | 19.53 | 14.98 | Upgrade |
EPS (Diluted) | 38.47 | 38.91 | 33.04 | 23.60 | 19.53 | 14.98 | Upgrade |
EPS Growth | 16.43% | 17.77% | 40.00% | 20.84% | 30.37% | -35.85% | Upgrade |
Dividend Per Share | 16.500 | 16.500 | 14.100 | 10.500 | 10.050 | 10.300 | Upgrade |
Dividend Growth | 17.02% | 17.02% | 34.29% | 4.48% | -2.43% | - | Upgrade |
Effective Tax Rate | 23.06% | 23.09% | 23.18% | 23.13% | 23.11% | 22.75% | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.